Journal of Neurogastroenterology and Motility : eISSN 2093-0887 / pISSN 2093-0879

Table. 1.

Baseline Characteristics of Study Participants

Characteristics NOVAponin(n = 61) Placebo(n = 51) (%) P-value
Sex
Male 8 (13.1) 18 (35.3) 0.006
Female 53 (86.9) 33 (64.7)
Age (yr) 52.28 ± 13.34 50.69 ± 13.52 0.533
Exercise
No 24 (39.3) 15 (29.4) 0.563
1-2 times/wk 17 (27.9) 14 (27.5)
3-4 times/wk 10 (16.4) 15 (29.4)
5-6 times/wk 4 (6.6) 3 (5.9)
Everyday 6 (9.8) 4 (7.8)
Smoking
Non-smoker 61 (100.0) 49 (96.0) 0.205
Ex-smoker 0 (0.0) 1 (2.0)
Smoker 0 (0.0) 1 (2.0)
Degree of stress
Nothing at all 5 (8.2) 5 (9.8) 0.633
A little bit 44 (72.1) 32 (62.8)
A lot of 10 (16.4) 10 (19.6)
Ton 2 (3.3) 4 (7.8)
Beverages containing Caffeine (U/day) 1.66 ± 1.00 1.39 ± 1.11 0.125
Chocolate (U/day) 0.10 ± 0.35 0.12 ± 0.38 0.987
Regularity of eating
Regular 40 (65.6) 34 (66.7) 0.903
Not regular 21 (34.4) 17 (33.3)
Time taken to eat one meal
Within 10 min 9 (14.8) 8 (15.7) 0.075
10 to 20 min 34 (55.7) 38 (74.5)
20 to 30 min 12 (19.7) 4 (7.8)
More than 30 min 6 (9.8) 1 (2.0)
Frequency of overeating
Less than 3 times/wk 49 (80.3) 42 (82.4) 0.785
3 or more times/wk 12 (19.7) 9 (17.6)
Alcohol drinking
No (never drink) 18 (29.5) 15 (29.4) 0.912
No (no drink) 9 (14.8) 9 (17.6)
Yes 34 (55.7) 27 (53.0)
A period of abstinence (mo) 30.67 ± 65.09 27.22 ± 25.38 0.339
Average alcohol consumption (U) 2.36 ± 2.05 2.44 ± 1.97 0.699

A P-value < 0.05 was considered statistically significant.

Data are presented as n (%) or mean ± SD.

J Neurogastroenterol Motil 2024;30:468~479 https://doi.org/10.5056/jnm23180
© J Neurogastroenterol Motil